SLC6A3 and impulse control disorder: The study was aimed at evaluating the role of DBH, DRD2, MAOA, BDNF, COMT, SLC6A4, SLC6A3, ACE, DRD1 gene polymorphisms in the development of ICD in PD patients receiving dopaminergic therapy.